NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-118-2021-0-PCT-02 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors PCT PCT PCT/US2022/032378 Expired
NCATS E-006-2022-0-US-01 LATS INHIBITORS AND USES THEREOF US 63/349,337 Expired
NHLBI E-025-2019-0-CA-05 ANTIBODIES TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF CA National Stage 3160855 Pending
NIAID E-193-2021-0-US-01 CELL-PENETRATING ANTIMICROBIAL AGENT US 63/365,841 Expired
NIAID E-080-2013-0-US-09 ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION US CON 17/831,259 12054749 Issued PDF
NHLBI E-045-2020-0-US-04 Cyclooxygenase-2 Inhibition For The Treatment Of SAA-high Asthma US National Stage 17/781,530 Pending
NIAID E-093-2022-0-US-01 COMPOSITIONS AND METHODS FOR DETECTING LYMPHATIC FILARIASIS US 63/347,794 Expired
NCI E-133-2016-0-JP-11 FLT3-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME JP DIV 2022-089863 Pending
NCI E-031-2021-0-PCT-02 NITROXIDE RADICALS AS ANTIVIRAL TREATMENT FOR CORONAVIRUS INFECTION PCT PCT PCT/US2022/031405 Expired
NHLBI E-085-2019-0-HK-06 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE HK EP 62022054258.8 Pending
NEI E-153-2020-0-PCT-02 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells PCT PCT PCT/US2022/031107 Expired
NCI E-044-2020-0-US-03 METHODS OF IDENTIFYING CELL-TYPE-SPECIFIC GENE EXPRESSION LEVELS BY DE-CONVOLVING BULK GENE EXPRESSION US National Stage 17/780,356 Pending
NHLBI E-186-2014-1-US-17 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 US CON 17/825,660 Pending
NEI E-155-2020-0-PCT-01 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS PCT PCT COMB PCT/US2022/031136 Expired
NIDDK E-112-2021-0-PCT-02 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases PCT PCT PCT/US2022/030935 Expired
NEI E-114-2023-0-US-01 OPHTHALMIC FORMULATION CAPABLE OF DELIVERING METFORMIN TO CHOROID RPE AND RETINA US 63/345,759 Expired
NCI E-149-2015-0-AU-07 Methods of Isolating T Cells and T Cell Receptors Having Antigen Specificaity for a Cancer-Specific Mutation from Peripheral Blood AU DIV 2022203507 Pending
NIAID E-103-2020-0-US-04 Broadly Neutralizing and Potent Antibodies Against HIV US National Stage 17/778,536 Pending
NCI E-230-2012-0-EP-70 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 EP DIV 22 174 521.9 Pending
NIAID E-103-2022-0-US-01 Replicating RNA Vaccine For Crimean-Congo Hemorrhagic Fever Virus US 63/365,015 Expired
NCI E-151-2019-0-CA-01 TASPASE1 INHIBITORS AND USES THEREOF CA National Stage 3162244 Pending
NCI E-151-2019-0-US-02 TASPASE1 INHIBITORS AND USES THEREOF US National Stage 17/777,971 Pending
NCATS E-128-2019-0-US-07 SALTS OF (2R, 6R)-HYDROXYNORKETAMINE, THEIR CRYSTAL FORMS, AND METHODS OF MAKING THE SAME US National Stage 17/777,654 Pending
NCI E-023-2019-0-US-05 INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS US National Stage 17/777,552 Pending
NCI E-205-2010-1-US-04 PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES US CON 17/746,740 Pending
NCI E-172-2022-0-US-01 Method Of Subtyping Of Small Cell Lung Cancer Using Plasma Cell-Free Nucleosomes US 63/342,763 Expired
NCI E-040-2012-0-US-65 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/745,067 Pending
NCI E-023-2019-0-CA-03 INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS CA National Stage 3158557 Pending
NCI E-209-2014-0-JP-20 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO JP DIV 2022-79474 Issued
NCI E-094-2022-0-US-01 PIM-TARGETED PROTACS AND METHODS OF USE US 63/341,757 Expired
NIAAA E-087-2021-0-PCT-02 A FACILE AND ODOR-FREE APPROACH TO CONVERT UREA/SULFONYL UREA TO CHALCOGENIDE UREA/ SULFONYL UREA PCT PCT PCT/US2022/028942 Expired
NCI E-233-2014-0-JP-11 METHODS FOR ISOLATING T CELL RECEPTORS HAVING ANTIGEN SPECIFICITY TO CANCER SPECIFIC MUTATIONS JP DIV 2022-077983 Issued
NIAID E-228-2016-1-US-14 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US CON 17/742,201 11793871 Issued PDF
NCI E-096-2021-0-PCT-02 LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS PCT PCT PCT/US2022/028819 Expired
NHLBI E-127-2021-2-PCT-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES PCT PCT COMB PCT/US2022/028510 Expired
NCI E-244-2015-0-EP-13 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use EP DIV 22172554.2 Pending
NCI E-126-2022-0-US-01 VACCINE FOR HUMAN T-LYMPHOTROPIC VIRUS-1 US 63/340,400 Expired
NICHD E-115-2022-0-US-01 NESTORONE® / TESTOSTERONE TRANSDERMAL GEL US 63/339,563 Expired
NEI E-192-2014-1-AU-11 Surgical Tool and Method for Ocular Tissue Transplantation AU DIV 2022203098 Pending
NIDA E-053-2016-2-US-07 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF US CON 17/738,301 12097196 Issued PDF
NCI E-192-2020-2-US-02 USE OF AGONISTS TO AUGMENT CAR T FUNCTION IN SOLID TUMORS US National Stage 17/775,262 Pending
NHLBI E-061-2022-0-US-01 SYSTEMS AND METHOD FOR SYNCHRONOUS CIRCUMFERENTIAL INTRAMYOCARDIAL
RESYNCHRONIZATION AND PACING 		US 63/364,319 Expired
NCI E-101-2021-0-PCT-02 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 PCT PCT PCT/US2022/028066 Expired
NHLBI E-119-2022-0-US-01 SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE US 63/338,654 Expired
NIAID E-128-2016-0-EP-07 MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONOVIRUSES EP DIV 22171378.7 Pending
NEI E-293-2016-0-JP-08 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV 2022-75904 Issued
NCI E-048-2022-0-US-01 COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS US 63/337,296 Expired
NHLBI E-123-2022-0-US-02 SYSTEMS AND METHODS FOR SPIRAL-IN-OUT LOW FIELD MRI SCANS US ORD 17/733,970 11747419 Issued PDF
NIAID E-089-2022-0-PCT-02 PREFUSION-STABILIZED LASSA VIRUS GLYCOPROTEIN COMPLEX AND ITS USE PCT PCT PCT/US2022/027136 Expired
NCI E-079-2020-2-US-02 IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN US National Stage 17/773,494 Pending